查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954583

全球排卵测试盒市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测（2026-2034）

Ovulation Testing Kits Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 请询问到货日

价格

排卵测试盒市场成长驱动因素

2025年全球排卵测试盒市场规模为2.664亿美元，预计将从2026年的2.829亿美元成长到2034年的4.897亿美元，预测期内（2026-2034年）年复合成长率为7.10%。北美地区在2025年将以74.20%的市场占有率领跑，这主要归功于多囊性卵巢症候群（PCOS）的高发生率、人们对生殖健康的重视以及家用检测解决方案的广泛应用。

排卵测试盒是女性追踪月经週期并确定排卵期的诊断工具。这些测试盒通常透过检测黄体生成素（LH）或黄体素代谢物的高峰来帮助女性更有效地规划怀孕。它们广泛用于排卵不规则的女性，尤其是患有PCOS的女性。

新冠疫情的影响

在2020年新冠疫情期间，由于供应链中断、产品供应有限以及妇科就诊量减少，市场保持了温和成长。然而，在2020年下半年，随着消费者越来越倾向于居家不孕症监测解决方案，市场需求显着回升。这种向自我检测和远距医疗辅助诊断的转变对市场的长期成长产生了积极影响。

市场趋势

对新产品发布和合作关係的关注度提高

随着人们对多囊性卵巢症候群（PCOS）和生育力追踪的认识不断提高，各公司加速推出创新产品。市场参与者增加数位化、可连接应用程式的排卵测试盒的数量，这些测试盒准确、快速且易于解读。

例如，2023年5月，Fridababy, LLC推出了一系列新的生育治疗产品，包括排卵预测测试和排卵/妊娠追踪套装。同样，在2023年7月，Proov与Quest Diagnostics Incorporated合作，扩大其家用生育力检测测试盒Confirm PdG的覆盖范围。这些举措提高产品的可及性，并加速其在全球的普及。

市场成长因素

多囊性卵巢症候群（PCOS）发生率上升

多囊性卵巢症候群（PCOS）是一种影响育龄女性的主要荷尔蒙失调疾病，通常会导致月经週期不规则和不孕症。根据世界卫生组织（WHO）（2023年6月）的资料，多囊性卵巢症候群（PCOS）影响全球约8-13%的女性，是导致不孕的主要原因之一。

在印度，根据美国国家生物技术资讯中心（NCBI）（2022年）的报告，根据雄性激素过多研究协会（AES）的调查，15-45岁女性中PCOS的盛行率约为10%；而根据美国国立卫生研究院（NIH）的调查，这一比例为5.8%。盛行率的上升是推动排卵测试盒需求成长的主要动力。

此外，排卵测试盒具有很高的准确性。根据 Cloudnine Fertility（2022年 11月）的资料，排卵预测测试盒的准确率约为 97%，这进一步推动了其普及。

限制

临床限制与假阳性风险

儘管排卵测试盒有很多优点，但它们也存在一些限制。根据 Dotdash Meredith（2023年 6月）发布的公告，排卵测试盒与激素类避孕药、促排卵药物和四环素类抗生素等药物合用时，可能会产生不准确的结果。

此外，虽然排卵测试盒可以以高达 99%的准确率检测到 LH 峰值，但它们不能确认排卵或保证怀孕。这些测试盒只能追踪排卵，无法侦测卵子活力，这项限制可能会阻碍其广泛应用。

市场区隔分析

依装置类型

市场依设备类型细分为数位设备、线指示设备和显微镜设备。

  • 预计到2026年，数位设备细分市场将占据89.57%的市场占有率，这主要得益于其高精度、快速出结果、可靠性和易用性。 线指示设备细分市场预计将实现最高的年复合成长率，这主要归功于其价格实惠且适合家庭使用。 显微镜设备细分市场预计将保持稳定成长，这主要得益于其可重复使用性和长期可用性。

依样本类型划分

依样本类型，市场分为血液、尿液和唾液三大类。

  • 预计到2026年，血液样本将占据市场主导地位，市场占有率高达 89.15%，这主要得益于其高精度以及与行动应用程式整合，便于结果追踪。
  • 由于新产品不断涌现，例如 Ro 公司于2020年 6月推出的尿液 LH 检测套装，尿液样本预计将实现显着成长。

依最终使用者划分

依最终用户划分，市场可分为生育中心、医院和诊所等机构。

  • 预计到2026年，生育治疗中心将成为市场占有率最大的细分市场，市场占有率达到 57.72%，这主要得益于全球生育治疗诊所数量的不断成长。
  • 随着患者越来越倾向于选择集检测和治疗于一体的医疗机构，医院和诊所领域预计将迎来显着成长。

区域概览

北美

北美在2025年占了最大的市场占有率（74.20%）。受多囊性卵巢症候群（PCOS）高发生率和人们对生育力检测的高度关注的推动，该地区的市场规模预计将在2026年达到2.104亿美元。

欧洲

欧洲占据了较大的市场占有率，这得益于Geratherm Medical AG和SPD Swiss Precision Diagnostics GmbH等主要公司的存在。该地区的优势在于其先进的医疗基础设施和生育治疗的广泛应用。

亚太地区

由于中国和印度不孕症病例数量不断增加、人们的意识不断提高以及数位医疗解决方案的普及，预计亚太地区在预测期内将实现显着成长。

世界其他地区

由于全球製造商持续进入尚未开发的市场，预计其他区域市场也将稳定成长。

主要公司

市场上主要的公司包括：

  • Piramal Pharma Ltd.
  • Geratherm Medical AG
  • SPD Swiss Precision Diagnostics GmbH
  • The Boots Company PLC
  • Proov
  • Ro
  • Wondfo
  • Everly Health, Inc.
  • Alfa Scientific Designs, Inc.
  • AdvaCare Pharma

这些各公司致力于併购、业务合作和产品创新，以巩固其市场地位。

产业主要动态

  • 2023年7月：Proov与2SAN GLOBAL LIMITED达成经销协议，扩大其在美国的产品分销。
  • 2023年5月：Frida Baby宣布推出全新生育治疗产品系列。
  • 2022年1月：Kindbody推出 "Kind at Home" 生育力检测套装。
  • 2021年5月：Ro收购Modern Fertility，拓展其生育治疗产品线。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家和地区女性不孕症盛行率（2025年）
  • 新产品发布
  • 主要产业趋势：併购、业务合作等
  • 新冠疫情对市场的影响

第5章 全球排卵测试盒市场分析：洞察与展望预测（2021-2034）

  • 市场分析、洞察与预测：依设备类型划分
    • 线指示器设备
    • 数位设备
    • 显微镜设备
  • 市场分析、洞察与预测：依样本类型划分
    • 尿液
    • 血液
    • 唾液
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和诊所
    • 生育中心
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区

第6章 北美排卵测试测试盒市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲排卵测试盒市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他欧洲国家

第8章 亚太地区排卵测试盒市场分析：洞察与预测（2021-2034）

  • 国家细分
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他亚洲国家太平洋

第9章 其他地区（ROW）排卵测试测试盒市场分析：洞察与预测（2021-2034）

第10章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • Piramal Pharma Ltd.
    • Geratherm Medical AG
    • SPD Swiss Precision Diagnostics GmbH
    • The Boots Company PLC
    • Alfa Scientific Designs, Inc.
    • Proov
    • Ro Wondfo
    • AdvaCare Pharma
    • Everly Health, Inc.
Product Code: FBI109709

Growth Factors of ovulation testing kits Market

The global ovulation testing kits market size was valued at USD 266.4 million in 2025 and is projected to grow from USD 282.9 million in 2026 to USD 489.7 million by 2034, exhibiting a CAGR of 7.10% during the forecast period (2026-2034). North America dominated the market with a 74.20% share in 2025, primarily due to the high prevalence of Polycystic Ovary Syndrome (PCOS), strong awareness regarding fertility health, and widespread adoption of at-home testing solutions.

Ovulation testing kits are diagnostic tools designed to help women track their menstrual cycle and determine their fertility window. These kits typically detect luteinizing hormone (LH) surge or progesterone metabolites, helping women plan pregnancy more effectively. They are widely used among women experiencing irregular ovulation, particularly those suffering from PCOS.

COVID-19 IMPACT

During the COVID-19 outbreak in 2020, the market experienced slow growth due to supply chain disruptions, limited product availability, and reduced visits to gynecologists. However, in the second half of 2020, demand rebounded significantly as consumers increasingly preferred home-based fertility monitoring solutions. This shift toward self-testing and telehealth-supported diagnostics positively influenced long-term market growth.

MARKET TRENDS

Increasing Focus on New Product Launches and Collaborations

Growing awareness regarding PCOS and fertility tracking has encouraged companies to introduce innovative products. Market players are increasingly launching digital and app-connected ovulation kits that offer accurate, quick, and easy-to-interpret results.

For instance, in May 2023, Fridababy, LLC launched a new line of fertility products, including an ovulation prediction test and ovulation & pregnancy tracking kits. Similarly, in July 2023, Proov collaborated with Quest Diagnostics Incorporated to expand access to Confirm PdG, an at-home fertility testing kit. Such initiatives are enhancing product availability and boosting global adoption.

MARKET GROWTH FACTORS

Increasing Prevalence of PCOS

Polycystic Ovary Syndrome (PCOS) is a leading hormonal disorder affecting reproductive-aged women, often causing irregular menstrual cycles and infertility. According to the World Health Organization (WHO) (June 2023), PCOS affects approximately 8-13% of women globally and is one of the leading causes of infertility.

In India, as per the National Center for Biotechnology Information (NCBI) (2022), the prevalence of PCOS was around 10% among women aged 15-45 years as per the Androgen Excess Society (AES), and 5.8% as per the National Institutes of Health (NIH). This rising prevalence is significantly driving demand for ovulation testing kits.

Additionally, ovulation kits offer high accuracy levels. According to Cloudnine Fertility (November 2022), ovulation prediction kits can be around 97% accurate, which further supports their adoption.

RESTRAINING FACTORS

Clinical Limitations and Risk of False Results

Despite their benefits, ovulation testing kits have certain limitations. According to an article published by Dotdash Meredith (June 2023), ovulation tests may provide inaccurate results when used alongside medications such as hormonal birth control, fertility drugs, or antibiotics containing tetracycline.

Moreover, while ovulation kits can detect LH surge with up to 99% effectiveness, they cannot confirm ovulation or guarantee pregnancy. Since these kits only track ovulation and not egg viability, their limitations may hinder broader adoption.

MARKET SEGMENTATION ANALYSIS

By Device Type

The market is segmented into digital devices, line indicator devices, and microscopic devices.

  • The digital devices segment is projected to hold 89.57% market share in 2026, driven by higher accuracy, faster results, reliability, and ease of use.
  • The line indicator devices segment is expected to record the fastest CAGR due to affordability and convenience for home use.
  • The microscopic devices segment is anticipated to grow steadily owing to reusability and long-term usability.

By Sample Type

Based on sample type, the market is segmented into blood, urine, and saliva.

  • The blood segment is expected to dominate with 89.15% share in 2026, attributed to higher accuracy and integration with mobile applications for result tracking.
  • The urine segment is anticipated to grow significantly due to increased product launches, such as Ro's urine-based LH detection kit launched in June 2020.

By End-User

The market is segmented into fertility centers, hospitals & clinics, and others.

  • The fertility centers segment is projected to lead with 57.72% share in 2026, supported by the rising number of fertility clinics globally.
  • The hospitals & clinics segment is expected to grow at a significant rate due to increasing patient preference for combined testing and treatment facilities.

REGIONAL INSIGHTS

North America

North America accounted for the largest market share in 2025 (74.20%). The regional market is estimated to reach USD 210.4 million in 2026, driven by high PCOS prevalence and strong awareness of fertility testing.

Europe

Europe holds a substantial market share due to the presence of key players such as Geratherm Medical AG and SPD Swiss Precision Diagnostics GmbH. The region benefits from advanced healthcare infrastructure and fertility treatment adoption.

Asia Pacific

Asia Pacific is projected to witness significant growth during the forecast period due to rising infertility cases in China and India, increasing awareness, and expanding access to digital health solutions.

Rest of the World

The market in other regions is expected to grow steadily due to the increasing penetration of global manufacturers into untapped markets.

KEY INDUSTRY PLAYERS

Major companies operating in the market include:

  • Piramal Pharma Ltd.
  • Geratherm Medical AG
  • SPD Swiss Precision Diagnostics GmbH
  • The Boots Company PLC
  • Proov
  • Ro
  • Wondfo
  • Everly Health, Inc.
  • Alfa Scientific Designs, Inc.
  • AdvaCare Pharma

These companies focus on mergers, acquisitions, partnerships, and product innovation to strengthen their market presence.

KEY INDUSTRY DEVELOPMENTS

  • July 2023: Proov signed a distribution agreement with 2SAN GLOBAL LIMITED to expand product distribution in the U.S.
  • May 2023: Fridababy launched new fertility product lines.
  • January 2022: Kindbody launched "Kind at Home" fertility test kits.
  • May 2021: Ro acquired Modern Fertility to expand fertility product offerings.

CONCLUSION

The global ovulation testing kits market is expected to grow from USD 266.4 million in 2025 to USD 489.7 million by 2034, rising at a CAGR of 7.10%. The market will expand to USD 282.9 million in 2026, driven by increasing PCOS prevalence, rising awareness about fertility health, and strong demand for home-based digital testing solutions. While limitations related to accuracy and medication interference remain challenges, ongoing product innovations, digital integration, and expanding fertility clinics are expected to sustain long-term market growth through 2034.

Segmentation By Device Type

  • Line Indicator Devices
  • Digital Devices
  • Microscopic Devices

By Sample Type

  • Urine
  • Blood
  • Saliva

By End-User

  • Hospitals & Clinics
  • Fertility Centers
  • Others

By Region

  • North America (By Device Type, Sample Type, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Device Type, Sample Type, End-user, and Country)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Device Type, Sample Type, End-user, and Country)
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia Pacific
  • Rest of the World (By Product, Sample Type, and End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Infertility Among Women - by Key Countries/Sub-region, 2025
  • 4.2. New Product Launches
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.4. Impact of COVID-19 on the Market

5. Global Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Device Type
    • 5.1.1. Line Indicator Devices
    • 5.1.2. Digital Devices
    • 5.1.3. Microscopic Devices
  • 5.2. Market Analysis, Insights and Forecast - By Sample Type
    • 5.2.1. Urine
    • 5.2.2. Blood
    • 5.2.3. Saliva
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Fertility Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Device Type
    • 6.1.1. Line Indicator Devices
    • 6.1.2. Digital Devices
    • 6.1.3. Microscopic Devices
  • 6.2. Market Analysis, Insights and Forecast - By Sample Type
    • 6.2.1. Urine
    • 6.2.2. Blood
    • 6.2.3. Saliva
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Fertility Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Device Type
    • 7.1.1. Line Indicator Devices
    • 7.1.2. Digital Devices
    • 7.1.3. Microscopic Devices
  • 7.2. Market Analysis, Insights and Forecast - By Sample Type
    • 7.2.1. Urine
    • 7.2.2. Blood
    • 7.2.3. Saliva
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Fertility Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Rest of the Europe

8. Asia Pacific Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Device Type
    • 8.1.1. Line Indicator Devices
    • 8.1.2. Digital Devices
    • 8.1.3. Microscopic Devices
  • 8.2. Market Analysis, Insights and Forecast - By Sample Type
    • 8.2.1. Urine
    • 8.2.2. Blood
    • 8.2.3. Saliva
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Fertility Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Rest of Asia Pacific

9. Rest of the World Ovulation Testing Kits Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Device Type
    • 9.1.1. Line Indicator Devices
    • 9.1.2. Digital Devices
    • 9.1.3. Microscopic Devices
  • 9.2. Market Analysis, Insights and Forecast - By Sample Type
    • 9.2.1. Urine
    • 9.2.2. Blood
    • 9.2.3. Saliva
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Fertility Centers
    • 9.3.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Piramal Pharma Ltd.
      • 10.2.1.1. Overview
      • 10.2.1.2. Products & services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. Geratherm Medical AG
      • 10.2.2.1. Overview
      • 10.2.2.2. Products & services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. SPD Swiss Precision Diagnostics GmbH
      • 10.2.3.1. Overview
      • 10.2.3.2. Products & services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. The Boots Company PLC
      • 10.2.4.1. Overview
      • 10.2.4.2. Products & services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. Alfa Scientific Designs, Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products & services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Proov
      • 10.2.6.1. Overview
      • 10.2.6.2. Products & services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Ro Wondfo
      • 10.2.7.1. Overview
      • 10.2.7.2. Products & services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. AdvaCare Pharma
      • 10.2.8.1. Overview
      • 10.2.8.2. Products & services
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Everly Health, Inc.
      • 10.2.9.1. Overview
      • 10.2.9.2. Products & services
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 2: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 3: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Ovulation Testing Kits Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 6: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 7: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Ovulation Testing Kits Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 10: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 11: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Ovulation Testing Kits Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 14: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 15: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Ovulation Testing Kits Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Rest of the World Ovulation Testing Kits Market Revenue (USD million) Forecast, by Device Type, 2021-2034
  • Table 18: Rest of the World Ovulation Testing Kits Market Revenue (USD million) Forecast, by Sample Type, 2021-2034
  • Table 19: Rest of the World Ovulation Testing Kits Market Revenue (USD million) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Ovulation Testing Kits Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Ovulation Testing Kits Market Value Share (%), by Device Type, 2025 & 2034
  • Figure 3: Global Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025 & 2034
  • Figure 4: Global Ovulation Testing Kits Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Ovulation Testing Kits Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 7: North America Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 8: North America Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 9: North America Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 10: North America Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 12: North America Ovulation Testing Kits Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Ovulation Testing Kits Market Value Share (%), By Country, 2025
  • Figure 14: Europe Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 15: Europe Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 16: Europe Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 17: Europe Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 18: Europe Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Ovulation Testing Kits Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Ovulation Testing Kits Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 23: Asia Pacific Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 24: Asia Pacific Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 25: Asia Pacific Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 26: Asia Pacific Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Ovulation Testing Kits Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Ovulation Testing Kits Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Rest of the World Ovulation Testing Kits Market Value (USD million), by Device Type, 2025 & 2034
  • Figure 31: Rest of the World Ovulation Testing Kits Market Value Share (%), by Device Type, 2025
  • Figure 32: Rest of the World Ovulation Testing Kits Market Value (USD million), by Sample Type, 2025 & 2034
  • Figure 33: Rest of the World Ovulation Testing Kits Market Value Share (%), by Sample Type, 2025
  • Figure 34: Rest of the World Ovulation Testing Kits Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Rest of the World Ovulation Testing Kits Market Value Share (%), by End-user, 2025
  • Figure 36: Global Ovulation Testing Kits Market Share (%), By Company, 2025